Dow gains 369 points on trader optimism about a COVID-19 treatment

US stocks rose on Friday as traders cheered news about advances in coronavirus treatment.
Gilead Sciences said on Friday that an analysis of clinical-trial data for its remdesivir drug found a 62% reduction in mortality risk among severe COVID-19 patients.
Still, the US on Thursday reported 63,200 new coronavirus cases, according to data from Johns Hopkins University.
Read more on Business Insider.
US stocks rose on Friday as news about advances in coronavirus treatment outweighed another record